Rise and shine, everyone, another sunny day is on the way. And here on the Pharmalot corporate campus, we are as busy as ever hustling short people to the school houses and ensuring the official mascots have fertilized the weeds. That is only the start. Our to-do list has grown quite long, so today is devoted to a larger-than-usual amount of R&D. We trust you relate. So no need to dawdle. Here are some tidbits. Hope your day goes well and stay in touch...
House Republicans To FDA: Fork Over Compounding Documents (Reuters)
New MS Pills Prompt Caution Among Doctors (Wall Street Journal)
Testosterone And Viagra: Not A Winning Combo For ED (Reuters)
Pfizer's Lyrica Shows Promise In Treating Fibromylagia (Pharma Times)
FDA Draft Guidance Seeks Clarity On IRB Oversight (Regulatory Focus)
Sanofi Diabetes Drug Wins EU Panel Recommendation (Bloomberg News)
Advisory Panel Moves To Make HIV Testing Routine (Reuters)
Bayer Walks Away From Schiff After Reckitt Raises Bid (Bloomberg News)
FDA OKs Ligand Drug For Hepatitis C (Bloomberg News)
FDA Adopts ICH Rule On Drug Substance Manufacturing (InPharma Technologist)
EDITOR'S NOTE: Please check this post for updates
1 Comment
You were in such a rush, you forgot your 'morning cup of stimulation?' Not a good idea, apparently; it may well be 'your secret weapon!'
http://bodyodd.nbcnews.com/_news/2012/11/20/15309215-coffee-helps-you-see-the-bright-side?lite